Education
About Us
Working with TipRanks
Follow Us
Profusa (PFSA)
NASDAQ:PFSA
PFSA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.40 - $13.25
Previous CloseN/A
VolumeN/A
Average Volume (3M)9.43M
Market Cap
$14.11M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.05
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding32,788,876
10 Day Avg. Volume12,063,815
30 Day Avg. Volume9,430,157
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Profusa News
PFSA FAQ
What was Profusa’s price range in the past 12 months?
Profusa lowest stock price was $0.40 and its highest was $13.25 in the past 12 months.
What is Profusa’s market cap?
Profusa’s market cap is $14.11M.
When is Profusa’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Profusa’s earnings last quarter?
Currently, no data Available
Is Profusa overvalued?
According to Wall Street analysts Profusa’s price is currently Overvalued.
Does Profusa pay dividends?
Profusa does not currently pay dividends.
What is Profusa’s EPS estimate?
Profusa’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Profusa have?
Profusa has 32,788,876 shares outstanding.
What happened to Profusa’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Profusa?
Currently, no hedge funds are holding shares in PFSA
Company Description
Profusa
A digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia
Profusa (PFSA) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
Technical Analysis
Silexion Therapeutics
―
NeueHealth Inc
―
CERo Therapeutics Holdings
―
New Era Energy & Digital
―
Beta Bionics, Inc.
―